|Mr. Stavros George Vizirgianakis B.Com.||Chief Exec. Officer, Pres and Director||23k||N/A||47|
|Mr. Robert Scott Ludecker||Sr. VP of Global Sales and Marketing||337.09k||N/A||50|
|Mr. Richard A. Zaremba||Sr. VP of Fin., Treasurer and Sec.||287.9k||250.74k||62|
|Mr. Dan Voic||VP of R&D and Engineering||217k||14.55k||55|
|Mr. Christopher H. Wright||VP of Domestic Sales||303.95k||N/A||42|
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various applications, such as spine, neuro, orthopedic, cosmetic, and laparoscopic surgeries, as well as in wound debridement, and other surgical and medical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Misonix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.